Insider Trading activities of Neogenomics Inc (NEO)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neogenomics Inc (NEO) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neogenomics Inc since year 2005. Table 2 shows the detailed insider transactions of Neogenomics Inc since 2005. The reporting company's ticker symbol is NEO. The reporting company's CIK number is 1077183.
The total value of stock buying since 2005 is $1,539,630.
The total value of stock sales since 2005 is $268,001,287.
The total value of stock option exercises since 2005 is $12,776,415.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Neogenomics Inc (NEO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-05 0 $0 458,223 $10,317,083 370,533 $2,208,191
2019-03 0 $0 14,000 $267,260 14,000 $112,419
2019-02 0 $0 594,979 $11,264,930 339,092 $2,402,463
2018-12 26,000 $301,600 10,835,145 $130,021,740 0 $0
2018-11 0 $0 4,674,815 $78,360,421 387,221 $1,745,374
2018-10 0 $0 0 $0 13,334 $46,002
2018-08 0 $0 119,948 $1,679,272 0 $0
2018-07 0 $0 83,552 $1,169,951 0 $0
2018-06 0 $0 493,474 $6,357,645 0 $0
2018-05 0 $0 329,466 $3,767,639 257,344 $904,439
2018-03 0 $0 0 $0 7,000 $33,460
2017-08 0 $0 0 $0 29,167 $125,514
2017-07 20,000 $183,800 0 $0 6,666 $22,997
2017-06 0 $0 81,556 $640,827 70,833 $308,477
2017-05 0 $0 3,334 $25,005 43,332 $0
2017-03 0 $0 83,100 $661,455 0 $0
2017-02 0 $0 0 $0 200,000 $342,000
2017-01 0 $0 0 $0 3,333 $15,931
2016-12 0 $0 0 $0 10,000 $16,900
2016-10 0 $0 0 $0 3,334 $3,667
2016-09 0 $0 168,175 $1,381,102 0 $0
2016-08 0 $0 370,000 $3,045,100 570,000 $1,580,610
2016-05 0 $0 692,132 $5,937,989 633,000 $1,183,740
2016-04 0 $0 112,500 $912,374 115,834 $446,959
2016-03 22,007 $149,195 482,000 $3,412,460 1,150,000 $1,020,000
2015-12 19,550 $155,777 0 $0 51,218 $80,412
2015-11 6,400 $49,977 385,000 $3,115,315 0 $0
2014-12 0 $0 107,082 $453,542 95,282 $130,960
2014-11 0 $0 33,200 $149,723 0 $0
2014-05 0 $0 110,000 $385,730 0 $0
2014-03 14,492 $50,852 0 $0 0 $0
2013-12 0 $0 111,561 $410,104 0 $0
2013-11 0 $0 112,969 $404,767 0 $0
2013-05 0 $0 10,000 $35,700 0 $0
2013-04 0 $0 130,000 $484,902 0 $0
2013-03 0 $0 300,000 $900,000 0 $0
2012-12 0 $0 641,439 $1,763,956 0 $0
2012-09 0 $0 138,955 $419,508 0 $0
2012-06 84,037 $141,860 0 $0 0 $0
2012-05 279,000 $474,140 0 $0 0 $0
2012-04 0 $0 15,602 $26,523 0 $0
2012-02 0 $0 70,055 $121,191 0 $0
2011-10 3,000 $3,630 28,000 $32,423 0 $0
2011-09 2,500 $2,849 0 $0 0 $0
2011-08 6,456 $8,031 0 $0 0 $0
2011-06 2,500 $3,375 10,000 $14,000 0 $0
2011-05 10,210 $14,544 45,000 $61,650 45,000 $45,900

Table 2. Detailed insider stock purchases, sales, and option exercises of Neogenomics Inc insiders (NEO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-05-08 Hipp Raymond R Sale 118,479 22.36 2,649,190
2019-05-07 Hipp Raymond R Sale 31,521 22.61 712,689
2019-05-06 Bonello William (Chief Strategy Officer) Sale 7,200 23.53 169,416
2019-05-06 Bonello William (Chief Strategy Officer) Option Ex 7,200 7.52 54,144
2019-05-03 Balliet Jennifer (VP and Chief Culture Officer) Sale 30,000 22.74 682,200
2019-05-03 Cardoza George (President, Pharma Services) Sale 151,676 22.82 3,461,246
2019-05-02 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 30,000 7.33 220,050
2019-05-02 Shovlin Robert J. (President, Clinical Services) Sale 119,347 22.14 2,642,342
2019-05-02 Shovlin Robert J. (President, Clinical Services) Option Ex 133,333 7.33 977,997
2019-05-02 Cardoza George (President, Pharma Services) Option Ex 200,000 4.78 956,000
2019-03-04 Balliet Jennifer (VP and Chief Culture Officer) Sale 14,000 19.09 267,260
2019-03-04 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 14,000 8.03 112,419
2019-02-28 Balliet Jennifer (VP and Chief Culture Officer) Sale 30,000 19.57 587,100
2019-02-28 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 30,000 7.78 233,250
2019-02-28 Shovlin Robert J. (President, Clinical Services) Option Ex 13,986 7.15 99,999
2019-02-27 Shovlin Robert J. (President, Clinical Services) Sale 44,135 19.23 848,716
2019-02-27 Cardoza George (President, Pharma Services) Option Ex 30,000 3.45 103,500
2019-02-27 Jones Steven C (Executive Vice President) Sale 285,252 18.84 5,374,147
2019-02-26 Shovlin Robert J. (President, Clinical Services) Sale 141,879 18.88 2,678,675
2019-02-26 Shovlin Robert J. (President, Clinical Services) Option Ex 186,014 7.33 1,364,412
2019-02-26 Jones Steven C (Executive Vice President) Sale 14,621 19.25 281,454
2019-02-26 Bonello William (Chief Strategy Officer) Sale 60,203 18.90 1,137,836
2019-02-26 Bonello William (Chief Strategy Officer) Option Ex 60,203 7.78 468,078
2019-02-26 Hipp Raymond R Sale 18,889 18.90 357,002
2019-02-26 Hipp Raymond R Option Ex 18,889 7.05 133,224
2018-12-21 Johnson Kevin C Buy 26,000 11.60 301,600
2018-12-14 Ge Medical Systems Information Technologies, Inc. (Other) Sale 10,835,145 12.00 130,021,740
2018-11-19 Tetrault Lynn A. Sale 13,000 15.98 207,805
2018-11-15 Tetrault Lynn A. Option Ex 18,888 7.68 145,059
2018-11-14 Tetrault Lynn A. Sale 5,000 16.16 80,800
2018-11-14 Jones Steven C (Executive Vice President) Sale 5,553 16.50 91,624
2018-11-13 Jones Steven C (Executive Vice President) Sale 35,574 16.68 593,196
2018-11-12 Balliet Jennifer (VP and Chief Culture Officer) Sale 28,505 16.73 476,888
2018-11-12 Shovlin Robert J. (President, Clinical Services) Sale 36,493 16.76 611,622
2018-11-12 Jones Steven C (Executive Vice President) Sale 100,000 16.66 1,666,000
2018-11-09 Ge Medical Systems Information Technologies, Inc. (10% Owner) Sale 4,164,855 16.75 69,761,321
2018-11-09 Balliet Jennifer (VP and Chief Culture Officer) Sale 39,828 17.00 677,076
2018-11-09 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 68,333 2.39 163,315
2018-11-09 Shovlin Robert J. (President, Clinical Services) Sale 180,000 17.05 3,069,000
2018-11-09 Shovlin Robert J. (President, Clinical Services) Option Ex 300,000 4.79 1,437,000
2018-11-09 Johnson Kevin C Sale 66,007 17.05 1,125,089
2018-10-22 Brodie Steven G. (VP - Pharma Operations) Option Ex 13,334 3.45 46,002
2018-08-01 Jones Steven C (Executive Vice President) Sale 119,948 14.00 1,679,272
2018-07-31 Jones Steven C (Executive Vice President) Sale 38,952 14.00 545,328
2018-07-30 Jones Steven C (Executive Vice President) Sale 44,600 14.01 624,623
2018-06-29 Shovlin Robert J. (President, Clinical Services) Sale 12,941 13.12 169,785
2018-06-22 Jones Steven C (Executive Vice President) Sale 89,688 14.04 1,259,219
2018-06-19 Jones Steven C (Executive Vice President) Sale 158,312 13.32 2,108,082
2018-06-15 Jones Steven C (Executive Vice President) Sale 2,000 13.25 26,500
2018-06-01 Jones Steven C (Executive Vice President) Sale 230,533 12.12 2,794,059
2018-05-31 Jones Steven C (Executive Vice President) Sale 17,548 11.68 204,960
2018-05-30 Jones Steven C (Executive Vice President) Sale 37,619 11.72 440,894
2018-05-29 Balliet Jennifer (VP and Chief Culture Officer) Sale 65,000 11.66 757,900
2018-05-29 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 65,000 4.78 310,700
2018-05-29 Jones Steven C (Executive Vice President) Sale 114,300 11.67 1,333,881
2018-05-25 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 6,666 .00 0
2018-05-25 Shovlin Robert J. (President, Clinical Services) Option Ex 16,666 .00 0
2018-05-25 Cardoza George (President, Pharma Services) Option Ex 8,333 .00 0
2018-05-25 Van Oort Douglas M (Chairman and CEO) Option Ex 65,680 .00 0
2018-05-15 Balliet Jennifer (VP and Chief Culture Officer) Sale 13,000 11.23 146,055
2018-05-15 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 13,000 4.78 62,140
2018-05-10 Ross Steven A (CIO) Sale 81,999 10.78 883,949
2018-05-10 Ross Steven A (CIO) Option Ex 81,999 6.48 531,599
2018-03-28 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 7,000 4.78 33,460
2017-08-24 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 22,500 3.60 81,112
2017-08-09 Hannah Alison L. (Director) Option Ex 6,667 6.66 44,402
2017-07-27 Hannah Alison L. (Director) Buy 20,000 9.19 183,800
2017-07-05 Brodie Steven G. (Vice President of Operations) Option Ex 6,666 3.45 22,997
2017-06-22 Balliet Jennifer (VP and Chief Culture Officer) Sale 10,723 8.49 91,038
2017-06-05 Ross Steven A (CIO) Sale 45,833 7.79 357,039
2017-06-02 Ross Steven A (CIO) Sale 25,000 7.71 192,750
2017-06-02 Ross Steven A (CIO) Option Ex 70,833 4.36 308,477
2017-05-30 Hannah Alison L. (Director) Option Ex 7,222 .00 0
2017-05-30 Tetrault Lynn A. (Director) Option Ex 7,222 .00 0
2017-05-30 Robison William J (Director) Option Ex 7,222 .00 0
2017-05-30 Johnson Kevin C (Director) Option Ex 7,222 .00 0
2017-05-30 Crowther Bruce K (Director) Option Ex 7,222 .00 0
2017-05-30 Hipp Raymond R (Director) Option Ex 7,222 .00 0
2017-05-26 Balliet Jennifer (VP and Chief Culture Officer) Sale 3,334 7.50 25,005
2017-03-20 Brodie Steven G. (President, Pharma Services) Sale 33,450 7.90 264,255
2017-03-13 Brodie Steven G. (President, Pharma Services) Sale 33,100 8.00 264,800
2017-02-02 Van Oort Douglas M (Chairman and CEO) Option Ex 200,000 1.71 342,000
2017-01-03 Johnson Kevin C (Director) Option Ex 3,333 4.78 15,931
2016-12-06 Brodie Steven G. (President, Pharma Services) Option Ex 10,000 1.69 16,900
2016-10-07 Balliet Jennifer (VP and Chief Culture Officer) Option Ex 3,334 1.10 3,667
2016-09-23 Albitar Maher (Chief Medical Officer) Sale 2,800 8.40 23,520
2016-09-20 Albitar Maher (Chief Medical Officer) Sale 105,300 8.20 863,459
2016-09-12 Albitar Maher (Chief Medical Officer) Sale 51,000 8.21 418,710
2016-09-09 Albitar Maher (Chief Medical Officer) Sale 9,075 8.31 75,413
2016-08-19 Albitar Maher (Chief Medical Officer) Sale 370,000 8.23 3,045,100
2016-08-19 Albitar Maher (Chief Medical Officer) Option Ex 570,000 2.77 1,580,610
2016-05-27 Van Oort Douglas M (Chairman and CEO) Sale 383,000 8.74 3,347,420
2016-05-26 Van Oort Douglas M (Chairman and CEO) Sale 98,387 8.69 854,983
2016-05-25 Van Oort Douglas M (Chairman and CEO) Option Ex 600,000 1.71 1,026,000
2016-05-18 Ross Steven A (CIO) Sale 18,000 8.50 153,000
2016-05-18 Ross Steven A (CIO) Option Ex 18,000 4.78 86,040
2016-05-09 Ross Steven A (CIO) Sale 15,000 8.22 123,300
2016-05-09 Ross Steven A (CIO) Option Ex 15,000 4.78 71,700
2016-05-02 Jones Steven C (Executive VP of Finance) Sale 177,745 8.21 1,459,286
2016-04-29 Balliet Jennifer (VP of Human Resources) Option Ex 3,334 1.45 4,834
2016-04-29 Ross Steven A (CIO) Sale 112,500 8.11 912,374
2016-04-29 Ross Steven A (CIO) Option Ex 112,500 3.93 442,125
2016-03-11 Cardoza George (Chief Financial Officer) Sale 32,000 6.83 218,560
2016-03-11 Cardoza George (Chief Financial Officer) Option Ex 100,000 1.46 146,000
2016-03-10 Brodie Steven G. (Chief Scientific Officer) Option Ex 50,000 1.48 74,000
2016-03-09 Van Oort Douglas M (Chairman and CEO) Sale 160,000 6.93 1,108,800
2016-03-08 Van Oort Douglas M (Chairman and CEO) Sale 290,000 7.19 2,085,100
2016-03-08 Van Oort Douglas M (Chairman and CEO) Option Ex 1,000,000 .80 800,000
2016-03-04 Johnson Kevin C (Director) Buy 7,207 6.84 49,295
2016-03-03 Johnson Kevin C (Director) Buy 14,800 6.75 99,900
2015-12-29 Horel Robert H. (Vice President GM PathLogic) Option Ex 51,218 1.57 80,412
2015-12-21 Tetrault Lynn A. (Director) Buy 9,500 8.21 77,995
2015-12-07 Tetrault Lynn A. (Director) Buy 3,500 7.72 27,020
2015-12-03 Shovlin Robert J. (Chief Operating Officer) Buy 6,550 7.75 50,762
2015-11-27 Aspen Select Healthcare Lp (10% Owner) Sale 35,000 8.06 282,065
2015-11-25 Aspen Select Healthcare Lp (10% Owner) Sale 350,000 8.10 2,833,250
2015-11-02 Crowther Bruce K (Director) Buy 6,400 7.81 49,977
2014-12-19 Horel Robert H. (Vice President andGM PathLogic) Sale 32,389 4.21 136,292
2014-12-19 Horel Robert H. (Vice President andGM PathLogic) Option Ex 32,389 1.25 40,583
2014-12-18 Horel Robert H. (Vice President andGM PathLogic) Sale 62,893 4.20 264,150
2014-12-18 Horel Robert H. (Vice President andGM PathLogic) Option Ex 62,893 1.44 90,377
2014-12-04 Dent Michael T (Director) Sale 11,800 4.50 53,100
2014-11-21 Dent Michael T (Director) Sale 19,037 4.52 85,990
2014-11-20 Dent Michael T (Director) Sale 14,163 4.50 63,733
2014-05-22 Gasparini Robert P (Chief Science Officer) Sale 100,000 3.49 349,200
2014-05-19 Gasparini Robert P (Chief Science Officer) Sale 10,000 3.65 36,530
2014-03-28 Albitar Maher (Chief Medical Officer) Buy 14,492 3.51 50,852
2013-12-17 Gasparini Robert P (Chief Science Officer) Sale 646 3.74 2,416
2013-12-12 Gasparini Robert P (Chief Science Officer) Sale 5,673 3.68 20,876
2013-12-11 Gasparini Robert P (Chief Science Officer) Sale 20,000 3.70 74,000
2013-12-10 Gasparini Robert P (Chief Science Officer) Sale 100 3.70 370
2013-12-09 Cardoza George (Chief Financial Officer) Sale 20,000 3.66 73,200
2013-12-05 Gasparini Robert P (Chief Science Officer) Sale 32,996 3.67 121,095
2013-12-03 Gasparini Robert P (Chief Science Officer) Sale 22,146 3.68 81,497
2013-12-02 Gasparini Robert P (Chief Science Officer) Sale 10,000 3.67 36,650
2013-11-25 Aspen Select Healthcare Lp (Executive VP of Finance) Sale 28,249 3.58 101,131
2013-11-22 Aspen Select Healthcare Lp (Executive VP of Finance) Sale 84,720 3.58 303,636
2013-05-02 Gasparini Robert P (Chief Science Officer) Sale 2,500 3.60 9,000
2013-05-01 Gasparini Robert P (Chief Science Officer) Sale 7,500 3.56 26,700
2013-04-30 Aspen Select Healthcare Lp (Executive VP of Finance) Sale 61,543 3.65 224,631
2013-04-30 Gasparini Robert P (Chief Science Officer) Sale 5,000 3.75 18,750
2013-04-29 Aspen Select Healthcare Lp (Executive VP of Finance) Sale 38,457 3.81 146,521
2013-04-29 Gasparini Robert P (Chief Science Officer) Sale 25,000 3.80 95,000
2013-03-05 Dent Michael T (Director) Sale 300,000 3.00 900,000
2012-12-20 Aspen Select Healthcare Lp (Executive VP of Finance) Sale 1,100 2.75 3,025
2012-12-19 Aspen Select Healthcare Lp (Executive VP of Finance) Sale 8,225 2.75 22,618
2012-12-18 Aspen Select Healthcare Lp (Executive VP of Finance) Sale 632,114 2.75 1,738,313
2012-09-28 Aspen Select Healthcare Lp (Executive VP of Finance) Sale 35,800 3.02 107,937
2012-09-28 Dent Michael T (Director) Sale 75,000 3.01 225,749
2012-09-26 Aspen Select Healthcare Lp (Executive VP of Finance) Sale 25,000 3.05 76,250
2012-09-26 Gasparini Robert P (Chief Science Officer) Sale 3,155 3.03 9,572
2012-06-20 Clearman Stephen J Buy 67,437 1.70 114,575
2012-06-19 Clearman Stephen J Buy 5,000 1.65 8,250
2012-06-18 Clearman Stephen J Buy 11,600 1.64 19,035
2012-05-17 Clearman Stephen J Buy 100,000 1.70 170,000
2012-05-15 Clearman Stephen J Buy 175,000 1.70 297,500
2012-05-02 Cardoza George (Chief Financial Officer) Buy 4,000 1.66 6,640
2012-04-30 Dent Michael T (Director) Sale 15,602 1.70 26,523
2012-02-22 Dent Michael T (Director) Sale 35,120 1.71 60,055
2012-02-21 Dent Michael T (Director) Sale 34,935 1.75 61,136
2011-10-26 Cardoza George (CFO) Buy 3,000 1.21 3,630
2011-10-24 Dent Michael T (Director) Sale 28,000 1.16 32,423
2011-09-15 Van Oort Douglas M (Chairman and CEO) Buy 2,500 1.14 2,849
2011-08-22 Van Oort Douglas M (Chairman and CEO) Buy 2,000 1.15 2,300
2011-08-08 Van Oort Douglas M (Chairman and CEO) Buy 2,000 1.30 2,600
2011-08-05 Van Oort Douglas M (Chairman and CEO) Buy 2,456 1.27 3,131
2011-06-13 Van Oort Douglas M (Chairman and CEO) Buy 2,500 1.35 3,375
2011-06-08 Dent Michael T (Director) Sale 5,000 1.40 7,000
2011-06-07 Dent Michael T (Director) Sale 5,000 1.40 7,000
2011-05-26 Van Oort Douglas M (Chairman and CEO) Buy 2,500 1.40 3,500
2011-05-18 Smits Mark W (Chief Commercial Officer) Sale 45,000 1.37 61,650
2011-05-18 Smits Mark W (Chief Commercial Officer) Option Ex 45,000 1.02 45,900
2011-05-17 Van Oort Douglas M (Chairman and CEO) Buy 1,110 1.40 1,554
2011-05-12 Van Oort Douglas M (Chairman and CEO) Buy 1,000 1.40 1,400
2011-05-10 Van Oort Douglas M (Chairman and CEO) Buy 600 1.40 840
2011-05-06 Van Oort Douglas M (Chairman and CEO) Buy 5,000 1.45 7,250

Insider trading activities including stock purchases, stock sales, and option exercises of NEO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neogenomics Inc (symbol NEO, CIK number 1077183) see the Securities and Exchange Commission (SEC) website.